Actualizado 14/02/2012 14:52
- Comunicado -

Procoralan® Receives European Approval for Use in Heart Failure (y 2)

6. Juenger J, Schellberg D et al. Health related quality of life in patients with congestive heart failure: comparison with other chronic diseases and relation to functional variables. Heart. 2002;87:235-241.

7. Procoralan Summary of Product Characteristics. http://www.emc.medicines.org.uk Last accessed May 2011

8. DiFrancesco D and Camm JA. Heart rate lowering by specific and selective I(f) current inhibition with ivabradine: a new therapeutic perspective in cardiovascular disease. Drugs 2004; 64(16): 1757-1765.

9. Tardif JC, O'Meara E, et al. Effects of selective heart rate reduction with ivabradine on left ventricular remodelling and function: results from the SHIFT echography substudy. Eur Heart J. 2011, DOI: 10.1093/eurheartj/ehr311. Available at http://eurheartj.oxfordjournals.org

For more information, please contact:

        
        Claire Martin, Reynolds-MacKenzie
        Tel: +44(0)-20-7861-2809
        Email: claire@reynoldsmackenzie.com
        Katy Gray, Reynolds-MacKenzie
        Tel: +44(0)20-7861-2806
        Email: katy@reynoldsmackenzie.com

Contenido patrocinado